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Aggressive low grade middle ear




Background: Primary tumours of the middle ear are much less commonly encountered in clinical practice than
non neoplastic lesions. Middle ear adenocarcinoma is a very rare, locally invasive neoplasm assumed to arise from
the middle ear mucosa. Because the natural course and clinical behavior of this neoplasm are far from established,
the sporadic reports of such cases continue to provide basis for better understanding.
Case description: A case of low grade adenocarcinoma of the middle ear is described in details with regard to its
clinical presentation, radiological findings, histopathological, immunohistochemical and ultrastructural findings. The
tumour recurred four times.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1687201235406811.
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Introduction
As a consequence of their rarity, middle ear neoplasms
may be difficult to classify, for both clinicians and
pathologists (Devaney etal.2003) [1]. Middle ear adeno-
carcinoma is a very rare, locally invasive neoplasm
assumed to arise from the middle ear mucosa. Although
endolymphatic sac tumor (aggressive papillary middle
ear tumor) and jugulotympanic paraganglioma may
show brain invasion, intracranial extension of histologi-
cally confirmed middle ear adenocarcinoma has not
been previously reported (Paulus etal 199) [2].
Case Report
A male patient presented at age 24 with a mass in the
right middle ear extending to the external auditory mea-
tus. He underwent surgery and the mass was diagnosed
as a simple polyp. One year later he presented with a
recurrent bleeding mass. The mass was re-excised and
the surgeon informed him that it was adherent to the
facial nerve and the patient ended up with a facial
paralysis. The mass was diagnosed as a middle ear ade-
noma. The patient was free of symptoms for 5 years
when he presented with a recurrent reddish mass in the
previous mastoid cavity filling it completely and peeping
through the Eustachian tube. The mass was completely
excised in September 2000 and the biopsy revealed a
middle ear adenoma.
The patient was followed up and was free until 2003
when routine MRI showed a huge mass extending
behind the mastoid cavity into the posterior cranial
fossa. The previous mastoid cavity was free of recur-
rence. A posterior fossa craniotomy was performed and
the mass partially excised as it was extremely bloody
and adherent to the cerebellum and brainstem. The
biopsy revealed it to be a middle ear adenocarcinoma.
The patient received post-operative radiotherapy on the
remnant and repeat follow-up MRI revealed it to be
stable. In 2005 a follow-up MRI was ordered for recur-
rent headaches and revealed a large mass in the middle
cranial fossa above the tegmen. The previous middle ear
and mastoid cavities were still free of recurrence. The
mass was excised by a middle fossa craniotomy and the
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last biopsy revealed an adenocarcinoma as well. The
patient has no family history of similar condition
Histologically the tumour cells are arranged in islands,
cords or form glandular spaces. The latter contain
brightly eosinophilic secretory material. Tumour cells
are cuboidal or oval with finely granular eosinophilic
cytoplasm and centrally placed cytologically bland
nuclei. (Figure 1)
Immunohistochemistry revealed that the tumour cells
are positive for keratin (Figure 2), vimentin (Figure 3), and
S100 protein but negative for chromogranin. Electron
microscopy revealed evidence of exocrine differentiation
in the form of apical membrane bound vesicles and elec-
tron dense granules. Surface microvilli have also been
found (Figure 4). The proliferation index was assessed by
Ki 67 immunostaining and it was about 1%. (Figure 5).
Discussion
As epithelial tumors as a group are rarities in the middle
ear, epithelial tumours of the middle ear of variable
degrees of aggressiveness have been considered together
in several reports [3-5]. Moreover an entity designated
aggressive papillary middle ear tumour has been recog-
nized; this term describes a middle ear tumour which
may, in contrast to middle ear adenoma, act in a particu-
larly aggressive fashion with intracranial extension [6,7].
Clearly, for the term middle ear adenoma to have any
meaning in isolation, it must refer to a tumor which does
not exhibit either light microscopic or clinical/radiologic
evidence of aggressive or malignant behavior [1]. In this
case report the light microscopic, immunohistochemical
and electron microscopic findings were similar to those
of middle ear adenoma. This tumor is considered to be
low grade based on histology and low proliferation index
but malignant based on aggressively invasive behavior, as
it recurred four times and it was invasive to the petrous
bone, posterior cranial fossa and middle cranial fossa.
The differential diagnosis of this tumour include papil-
lary adenocarcinoma (aggressive papillary tumor) of the
middle ear which has a papillary-to-glandular appear-
ance and may produce a colloid-like substance and
resemble papillary carcinomas of the thyroid. It has
been suggested that this may be the same tumor as low
grade adenocarcinoma of endolymphatic sac origin,
which has locally extended into the middle ear. These
tumors are immunohistochemically positive for cytoker-
atin, epithelial membrane antigen, and S100 protein. In
the present case the tumour showed no papillae, and it
remains to be verified whether similar tumours can ori-
ginate from the middle ear. Paulus etal. 1999 [2]
described a 53-year-old man who suffered from otalgia
Figure 1 A photomicrograph of the tumor. It is made up of
epithelial cells with eosinophilic cytoplasm, arranged in trabeculae
and glandular spaces containing eosinphilic material. (H& E stain).
Figure 2 positive immunohistochemical staining of the tumor
cells for cytokeratin.
Figure 3 Positive immunohistochemical staining of the tumor
for vimentin.
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and tinnitus for more than 10 years and from neurologi-
cal deficits for 1 year due to a large temporal bone
tumor that invaded the temporal lobe. A combined neu-
rosurgical and otolaryngological resection was per-
formed. Pathological analysis revealed a low-grade
adenocarcinoma of a mixed epithelial–neuroendocrine
phenotype, which showed a close histological similarity
to, and topographical relationship with, middle ear
epithelium. The authors conclude that middle ear ade-
nocarcinoma belongs to the spectrum of extracranial
tumors that have possible local extension to the brain.
Conclusion
Every individual case of middle ear adenomatous tumor
requires a detailed clinical and radiological workup. All
cases should be managed aggressively with an attempt
at tumor removal. Regular follow-up with sequential
radiology is essential.
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Figure 5 Ki-67 immunostaining showing low proliferation
index.
Figure 4 An electron micrograph of the tumor cells showing
apical vesicles (thick blue arrows) and electron dense granules
(thin arrows). (original magnification 6000, urinyl acetate and lead
citrate)
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